secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2024-09-20T23:59:59+00:00
Accession:  0001493152-24-037600
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics receives Nasdaq extension to continue listing through November 19, 2024
--------------------------------------------------------------------------------

- Received Nasdaq Hearings Panel notice on Sept 11, 2024 granting extension for continued listing.
- Must evidence compliance with all applicable Nasdaq criteria by November 19, 2024.
- Company is diligently working to fulfill requirements for continued listing on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224037600/0001493152-24-037600-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224037600/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-037600

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer